Erratum: Docking of insulin to a structurally equilibrated insulin receptor ectodomain (Originally Published in Proteins (2010) 78 (1531-1543) DOI: 10.1002/prot.22670);Dockina of insulin to a structurally equilibrated insulin receptor ectodomain

Proteins: Structure, Function and Bioinformatics

Volumn 78, Issue 6, 2010, Pages 1531-1543

  Vashisth, Harish ^a   Abrams, Cameron F ^a  

^a Drexel University   (United States)

Author keywords

Conformational flexibility; Hormone recognition; Insulin receptor site 2; Molecular dynamics; Montecarlo docking; See saw mechanism

Indexed keywords

DIMER; DISULFIDE; EPITOPE; FIBRONECTIN; INSULIN; INSULIN RECEPTOR; PROTEIN TYROSINE KINASE; AMINO ACID; APOPROTEIN; MUTANT PROTEIN; PROTEIN SUBUNIT;

ARTICLE; BINDING SITE; CONTROLLED STUDY; CRYSTAL STRUCTURE; CRYSTALLOGRAPHY; HORMONE RECEPTOR INTERACTION; INSULIN BINDING; MOLECULAR DOCKING; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN QUATERNARY STRUCTURE; PROTEIN STRUCTURE; SIMULATION; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; PLIABILITY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE;

RUMEX;

AMINO ACIDS; APOPROTEINS; HUMANS; INSULIN; MODELS, MOLECULAR; MUTANT PROTEINS; PLIABILITY; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECEPTOR, INSULIN;

EID: 77951214213     PISSN: 08873585     EISSN: 10970134     Source Type: Journal    
DOI: 10.1002/prot.22740     Document Type: Erratum

References (56)

1. De Meyts P, Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 2002; 1: 769-783. (Pubitemid 37361561)
2. Ward CW, Lawrence MC, Streltsov VA, Adams TE, McKern NM. The insulin and EGF receptor structures: new insights into ligandinduced receptor activation. Trends Biochem Sci 2007; 32: 129-137.
3. Sparrow LG, Lawrence MC, Gorman JJ, Strike PM, Robinson CP, McKern NM, Ward CW. N-linked glycans of the human insulin receptor and their distribution over the crystal structure. Proteins 2008; 71: 426-439.
4. Lawrence MC, McKern NM, Ward CW. Insulin receptor structure and its implications for the IGF-1 receptor. Curr Opin Struct Biol 2007; 17: 699-705. (Pubitemid 350180400)
5. Kitamura T, Kahn CR, Accili D. Insulin receptor knockout mice. Annu Rev Physiol 2003; 65: 313-332.
6. 6. Czech MP. The nature and regulation of the insulin receptor; structure and function. Annu Rev Physiol 1985; 47: 357-381. (Pubitemid 15142387)
7. 7. Ward C, Lawrence M, Streltsov V, Garrett T, McKern N, Lou MZ, Lovrecz G, Adams T. Structural insights into ligand-induced activation of the insulin receptor. Acta Physiol 2008; 192: 3-9. (Pubitemid 350265361)
8. De Meyts P. Insulin interactions with its receptors: experimental evidence for negative coo-operativity. Biochem Biophys Res Commun 1973; 55: 154-161.
9. 9. De Meyts P. Insulin and its receptor: structure, function and evolution. BioEssays 2004; 26: 1351-1362. (Pubitemid 39664629)
10. Schäffer L. A model for insulin binding to the insulin receptor. Eur J Biochem 1994; 221: 1127-1132.
11. Flörke RR, Schnaith K, Passlack W, Wiehert M, Kuehn L, Fabry M, Federwisch M, Reinauer H. Hormone-triggered conformational changes within the insulin-receptor ectodomain: requirement for transmembrane anchors. Biochem J 2001; 360: 189-198. (Pubitemid 33081964)
12. De Meyts P. The structural basis of insulin and insulin-like growth factor-I receptor binding and negative co-operativity, and its relevance to mitogenic versus metabolic signalling. Diabetologia 1994; 37(Suppl 2): S135-S148. (Pubitemid 24288803)
13. McKern NM, Lawrence MC, Streltsov VA, Lou M, Adams TE, Lovrecz GO, Elleman TC, Richards KM, Bentley JD, Pilling PA, Hoyne PA, Cartledge KA, Pham TM, Lewis JL, Sankovich SE, Stoichevska V, Silva ED, Robinson CP, Frenkel MJ, Sparrow LG, Fernley RT, Epa VC, Ward CW. Structure of the insulin receptor ectodomain reveals a folded-over conformation. Nature 2006; 443: 218-221. (Pubitemid 44387610)
14. Chan SJ, Nakagawa S, Steiner DF. Complementation analysis demonstrates that insulin cross-links both ct-subunits in a truncated insulin receptor dimer. J Biol Chem 2007; 282: 13754-13758. (Pubitemid 47100560)
15. Kiselyov W, Versteyhe S, Gauguin L, De Meyts P. Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation. Mol Syst Biol. 2009; 5: 1-12.
16. Williams PF, Mynarcik DC, Yu GW, Whittaker J. Mapping of an NH2-terminal ligand binding site of the insulin receptor by alanine scanning mutagenesis. J Biol Chem 1995; 270: 3012-3016.
17. Mynarcik DC, Williams PF, Schaffer L, Yu GQ, Whittaker J. Analog binding properties of insulin receptor mutants. J Biol Chem 1997; 272: 2077-2081.
18. Schaefer EM, Siddle K, Ellis L. Deletion analysis of the human insulin receptor ectodomain reveals independently folded soluble subdomains and insulin binding by a monomeric ct-subunit. J Biol Chem 1990; 265: 13248-13253. (Pubitemid 20234279)
19. Kristensen C, Andersen AS, Hach M, Wiberg FC, Schärfer L, Kjeldsen T. A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the Insulin receptor. Biochem J 1995; 305: 981-986.
20. Schlein M, Havelund S, Kristensen C, Dunn MF, Kaarsholm NC. Ligand-induced conformational change in the minimized insulin receptor. J Mol Biol 2000; 303: 161-169.
21. Brandt J, Andersen AS, Kristensen C. Dimeric fragment of the insulin receptor ct-subunit binds insulin with full holoreceptor affinity. J Biol Chem 2001; 276: 12378-12384. (Pubitemid 37385410)
22. Surinya KH, Molina L, Soos MA, Brandt J, Kristensen. C, Siddle K. Role of insulin receptor dimerization domains in ligand binding, cooperativity, and modulation by anti-receptor antibodies. J Biol Chem 2002; 277: 16718-16725. (Pubitemid 34967692)
23. Kristensen C, Andersen AS, Østergaard S, Hansen PH, Brandt J. Functional reconstitution of insulin receptor binding site from nonbinding receptor fragments, J Biol Chem 2002; 277: 18340-18345.
24. Pullen RA, Lindsay DG, Wood SP, Tickle IJ, Blundell TL, Wollmer A, Krail G, Brandenburg D, Zahn H, Gliemann J, Gammeltoft S. Receptor-binding region of insulin. Nature 1976; 259: 369-373.
25. De Meyts P, Obberghen EV, Roth J, Wollmer A, Brandenburg D. Mapping of the residues responsible for the negative cooperativity of the receptor-binding region of insulin. Nature 1978; 273: 504-509. (Pubitemid 8346576)
26. Kristensen C, Kjeldsen T, Wiberg FC, Schärfer L, Hach M, Havelund S, Bass J, Steiner DF, Andersen AS. Alanine scanning mutagenesis of insulin. J Biol Chem 1997; 272: 12978-12983.
27. Chen H, Shi M, Guo ZY, Tang YH, Qiao ZS, Liang ZH, Feng YM. Four new monomeric insulins obtained by alanine scanning the dimer-forming surface of the insulin molecule. Protein Eng 2000; 13: 779-782. (Pubitemid 32127576)
28. Kurose T, Pashmforoush M, Yoshimasa Y, Carroll R, Schwartz GP, Burke GT, Katsoyannis PG, Steiner DF. Cross-linking of a B25 Azidophenylalanine insulin derivative to the carboxyl-terminal regions of the ct-subunit of the insulin receptor. J Biol Chem 1994; 269: 29190-29197.
29. Mynarcik DC, Yu GQ, Whittaker J. Alanine-scanning mutagenesis of a C-terminal ligand binding domain in the insulin receptor a subunit. J Biol Chem 1996; 271: 2439-2442. (Pubitemid 26047846)
30. Kristensen C, Wiberg FC, Andersen AS. Specificity of insulin and insulin-like growth factor I receptors investigated using chimeric mini-receptors. J Biol Chem 1999; 274: 37351-37356.
31. Molina L, Marino-Busije C, Quinn DR, Siddle K. Structural domains of the insulin receptor and IGF receptor required for dimerization and. ligand binding. FEBS Lett 2000; 467: 226-230. (Pubitemid 30081739)
32. Zhang B, Roth RA. A region of the insulin receptor important for ligand binding (residues 450-601) is recognized by patients' autoimmune antibodies and inhibitory monoclonal antibodies. Proc Natl Acad Sci USA 1991; 88: 9858-9862. (Pubitemid 21915733)
33. Fabry M, Schaefer E, Ellis L, Kojro E, Fahrenholz F, Brandenburg D. Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J Biol Chem 1992; 267: 8950-8956.
34. Schumacher R, Soos MA, Schlessinger J, Brandenburg D, Siddle K, Ullrich A. Signaling-competent receptor chimeras allow mapping of major insulin receptor binding domain determinants. J Biol Chem 1993; 268: 1087-1094. (Pubitemid 23019746)
35. Hao C, Whittaker L, Whittaker J. Characterization of a second ligand binding site of the insulin receptor. Biochem Biophys Res Commun 2006; 347: 334: 339. (Pubitemid 44015681)
36. Benyoucef S, Surinya KH, Hadaschik D, Siddle K. Characterization of insulin/IGF hybrid receptors: contributions of the insulin receptor L2 and Fn1 domains and the alternatively spliced exou 11 sequence to ligand binding and receptor activation. Biochem J 2007; 403: 603-613. (Pubitemid 46706989)
37. Whittaker L, Hao C, Fu W, Whittaker J. High-affinity insulin binding: insulin interacts with two receptor ligand binding sites. Biochemistry 2008; 47: 12900-12909.
38. Xu B, Hu SQ, Chu YC, Huang K, Nakagawa SH, Katsoyannis PG, Weiss MA. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor. Biochemistry 2004; 43: 8356-8372. (Pubitemid 38902515)
39. Huang K, Xu B, Hu SQ, Chu YC, Hua QX, Qu Y, Li B, Wang S, Wang RY, Nakagawa SH, Theede AM, Whittaker J, De Meyts P, Katsoyannis PG, Weiss MA. How insulin binds: the B-chain α-helix contacts the LI β-helix of the insulin receptor. J Mol Biol 2004; 341: 529-550. (Pubitemid 38987787)
40. Huang K, Chan SJ, Hua QX, Chu YC, Wang R, Klaproth B, Jia W, Whittaker J, De Meyts P, Nakagawa SH, Steiner DF, Katsoyannis PG, Weiss MA. The A-chain of insulin contacts the insert domain of the insulin receptor. J Biol Chem 2007; 282: 35337-35349.
41. Lawrence M. Private communication.
42. Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, Chipot C, Skeel RD, Kalé L, Schulten K. Scalable molecular dynamics with NAMD. J Comput Chem 2005; 26: 1781-1802.
43. MacKerell AD, Jr., Bashford D, Bellott M, Dunbrack RL, Jr, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha. S, Joseph-McCarthy D, Kuchnir L, Kuczera K, Lau FTK, Mattos C, Michnick S, Ngo T, Nguyen DT, Prodhom B, Reiher III, WE, Roux B, Schlenkrich M, Smith JC, Stote R, Straub J, Watanabe M, Wiórkiewicz-Kuczera J, Yin D, Karplus M. All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 1998; 102: 3586-3616. (Pubitemid 128576688)
44. MacKerell AD, Jr., Feig M, Brooks CL, III., Extending the treatment of backbone energetics in protein force fields: limitations of gasphase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations. J Comput Chem 2004; 25: 1400-1415.
45. Humphrey W, Daike A, Schulten. K. VMD-visual molecular dynamics. J Mol Graph 1996; 14: 33-38.
46. Lou M, Garrett TPJ, McKern NM, Hoyne PA, Epa VC, Bentley JD, Lovrecz GO, Cosgrove LJ, Frenkel MJ, Ward CW. The first three domains of the insulin receptor differ structurally from the insulinlike growth factor 1 receptor in the regions governing ligand specificity. Proc Natl Acad Sci USA 2006; 103: 12429-12434. (Pubitemid 44267276)
47. Nakagawa SH, Tager HS. Role of the phenylalanine B25 side chain in directing insulin inter-action with its receptor. J Biol Chem 1986; 261: 7332-7341.
48. Kadowaki H, Kadowaki T, Cama A, Marcus-Samuels B, Rovira A, Bevins CL, Taylor SI. Mutagenesis of Lysine 460 in the human insulin receptor. J Biol Chem 1990; 265: 21285-21296.
49. Soos MA, Siddle K, Baron MD, Heward JM, Luzio JP, Bellatin J, Lennox ES. Monoclonal antibodies reacting with multiple epitopes on the human insulin receptor. Biochem J 1986; 235: 199-208. (Pubitemid 16041992)
50. Whittaker J, Garcia P, Yu GQ, Mynarcik DC. Transmembrane domain interactions are necessary for negative cooperativity of the insulin-receptor. Mol Endocrinol 1994; 8: 1521-1526.
51. Sparrow LG, McKern NM, Gorman JJ, Strike PM, Robinson CP, Bentley JD, Ward CW. The disulfide bonds in the C-terminal domains of the human insulin receptor ectodomain. J Biol Chem 1997; 272: 29460-29467.
52. Nakagawa SH, Zhao M, Hua QX, Hu SQ, Wan ZL, Jia W, Weiss MA. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain. Biochemistry 2005; 44: 4984-4999.
53. Renteria ME, Gandhi HS, Vinuesa P, Helmerhorst E, Mancera RL. A comparative structural bioinformatics analysis of the insulin receptor family ectodomain based on phylogenetic information. PLoS ONE 2008; 3: e3667.
54. De Meyts P. The insulin receptor: a prototype for dimeric, allosteric membrane receptors? Trends Biochem Sci 2008; 33: 376-384.
55. 55. Jensen M, Hansen B, De Meyts P, Schaeffer L, Urso B. Activation of the insulin receptor by insulin and a synthetic peptide leads to divergent metabolic and mitogenic signaling and responses. J Biol Chem 2007; 282: 35179-35186. (Pubitemid 350232483)
56. Catlett C, Allcock WE, Andrews P, Aydt R, Bair R, Balac N, Banister B, Barker T, Bartelt M, Beckman P, Berman F, Bertoline G, Blatecky A, Boisseau J, Bottum J, Brunett S, Bunn J, Butler M, Carver D, Cobb J, Cockerill T, Couvares PF, Dahan M, Diehl D, Dunning T, Foster I, Gaither K, Gannon D, Goasguen S, Grobe M, Hart D, Heinzel M, Hempel C, Huntoon W, Insley J, Jordan C, Judson I, Kamrath A, Karonis N, Kesselman C, Kovatch P, Lane L, Lathrop S, Levine M, Lifka D, Liming L, Livny M, Loft R, Marcusiu. D, Marsteller J, Martin S, McCaulay S, McGee J, McGinnis L, McRobbie M, Messina P, Moore R, Moore R, Navarro JP, Nichols J, Papka ME, Pennington R, Pike G, Pool J, Reddy R, Reed D, Rimovsky T, Roberts E, Roskies R, Sanielevici S, Scott JR, Shankar A, Sheddon M, Showerman M, Simmel D, Singer A, Skow D, Smallen S, Smith W, Song C, Stevens R, Stewart C, Stock RB, Stone N, Towns J, Urban T, Vildibill M, Walker E, Welch V, Wilkins-Diehr N, Williams R, Winkler L, Zhao L, Zimmerman A. Teragrid: analysis of organization, system architecture, and middleware enabling new types of applications. In: Grandinetti L, editor. HPC and grids in action. Amsterdam: IOS press; 2007.